Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRIMA EU Retrospective & Prospective

NCT: NCT06371833 · RECRUITING

NCT IDNCT06371833
StatusRECRUITING
Start Date2024-10-25
Completion2030-01
SponsorLimacorporate S.p.a (INDUSTRY)
First posted
Last updated

Brief Summary

This clinical study aims at evaluating clinical, radiographic and patient-reported outcomes after total anatomic or reverse shoulder replacement using PRIMA humeral stem up to 24 months after surgery, in order to assess the short-term performance of the implant. Furthermore, the objective is also to collect short-term data on the survivorship of the implant and the incidence of complications.

Frequently Asked Questions

What is PRIMA EU Retrospective & Prospective?

PRIMA EU Retrospective & Prospective is a clinical trial registered under NCT06371833. Current status: RECRUITING.

What is the status of NCT06371833?

The current status of NCT06371833 (PRIMA EU Retrospective & Prospective) is: RECRUITING.

When did PRIMA EU Retrospective & Prospective start?

PRIMA EU Retrospective & Prospective started on 2024-10-25.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.